Table 2: Change in dosage, psychiatric symptoms, and social functions from baseline (T1) to the 4th month (T2).

(n=99) CR+SE SE F
(n=50) (n=49)
Mean S.D. Mean S.D. Time (T) Group (G) T×G
Antipsychotics medication
(mg/day)a 		pre 646.51 1011.32 423.42 295.42 0.346 0.935 0.158
post 709.62 1070.67 427.30 293.21      
PANSS(Psychiatric Symptoms)                
Positive scale pre 14.44 5.33 12.76 5.05 0.238 2.531 0.845
post 13.52 5.24 12.61 5.57      
Negative scale pre 18.50 5.73 15.51 5.70 0.116 0.080 0.815
post 17.20 5.21 14.94 6.05      
General Psychopathology scale pre 34.86 9.20 28.69 9.90 0.160 0.240 2.416
post 31.86 9.26 28.41 10.70      
Total Score pre 67.80 16.96 56.96 18.87 1.976 2.306 3.490†
post 62.58 17.13 55.96 20.90      
LASMIb (Social Functions)                
Interpersonal relations pre 18.50 8.88 15.00 7.46 0.596 0.107 11.695**
post 14.40 8.24 14.71 7.38      
Working related behavior pre 15.04 6.99 13.63 6.35 3.374† 7.437* 3.103†
post 12.42 5.46 13.13 5.17      

** p<.01, * p<.05, † p<.10
a: CPZ equivalent dose b:LASMI:Life Assessment scale for the Mentally Ill c:JART:Japanese Adult Reading Test (b and c are available only in Japanese)